reviewThe Lancet OncologyMay 8, 2016GREEN OA

FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis

MSMustafa SukerBRBerend R. BeumerESEran SadotLMLysiane MartheyJEJason E. Faris

Erasmus University Rotterdam · Memorial Sloan Kettering Cancer Center · +18 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

909
total citations
FWCI
40.72
Percentile
100%
References
43
Citations per year

Authors

20

Topics & keywords

Topics
Keywords
  • FOLFIRINOX
  • Medicine
  • Irinotecan
  • Internal medicine
  • Pancreatic cancer
  • Chemoradiotherapy
  • Oxaliplatin
  • Oncology
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.